Pharma Sentinel is a pioneering digital HealthTech B2C/B2B startup based in London, UK, and owns subsidiary brand Medsii.
Pharma Sentinel's app Medsii Provides You & Your Loved Ones With Trusted, Customized Health & Medicines News and Alerts and Links You with Helpful Patient Support Groups. Medsii provides you with personalized and customized news & alerts for health, medicines & medical conditions from trusted sources such as the World Health Organization, the NHS, EMA, and FDA and also allows side-effect reporting (pharmacovigilance). Our platform is patient-centric, robust, scalable, secure, and GDPR compliant. We are a One-Stop Shop, democratizing medicines news data to help *you and your loved ones* Skincare, Diabetes, Stress, Sickle Cell Disease, Heart Disease, Menopause, Malaria, IVF, Stopping Smoking.
Total Funding: $260 K
Funding Stage: Pre-Seed
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 1 to 25
Founded: 2019